DK1169026T3 - Anvendelse af AP-1-aktivator til at behandle glaucom og okular hypertension - Google Patents

Anvendelse af AP-1-aktivator til at behandle glaucom og okular hypertension

Info

Publication number
DK1169026T3
DK1169026T3 DK00921979T DK00921979T DK1169026T3 DK 1169026 T3 DK1169026 T3 DK 1169026T3 DK 00921979 T DK00921979 T DK 00921979T DK 00921979 T DK00921979 T DK 00921979T DK 1169026 T3 DK1169026 T3 DK 1169026T3
Authority
DK
Denmark
Prior art keywords
activator
ocular hypertension
treat glaucoma
glaucoma
treat
Prior art date
Application number
DK00921979T
Other languages
Danish (da)
English (en)
Inventor
Iok-Hou Pang
Abbot F Clark
Debra L Shade
Original Assignee
Alcon Mfg Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Mfg Ltd filed Critical Alcon Mfg Ltd
Application granted granted Critical
Publication of DK1169026T3 publication Critical patent/DK1169026T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DK00921979T 1999-04-20 2000-04-07 Anvendelse af AP-1-aktivator til at behandle glaucom og okular hypertension DK1169026T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13013399P 1999-04-20 1999-04-20

Publications (1)

Publication Number Publication Date
DK1169026T3 true DK1169026T3 (da) 2004-10-04

Family

ID=22443214

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00921979T DK1169026T3 (da) 1999-04-20 2000-04-07 Anvendelse af AP-1-aktivator til at behandle glaucom og okular hypertension

Country Status (12)

Country Link
EP (1) EP1169026B1 (ja)
JP (1) JP2002542189A (ja)
AT (1) ATE270883T1 (ja)
AU (1) AU766199B2 (ja)
BR (1) BR0009862A (ja)
CA (1) CA2369126A1 (ja)
DE (1) DE60012163T2 (ja)
DK (1) DK1169026T3 (ja)
ES (1) ES2223502T3 (ja)
HK (1) HK1039568B (ja)
PT (1) PT1169026E (ja)
WO (1) WO2000062769A2 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2317999A2 (en) 2008-07-04 2011-05-11 Institut National De La Sante Et De La Recherche Medicale (Inserm) Methods for modulating angiogenesis via dystrophin dp71

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981568A (en) * 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
CN1169857A (zh) * 1996-07-10 1998-01-14 林东和 降眼压活性组合物

Also Published As

Publication number Publication date
ES2223502T3 (es) 2005-03-01
HK1039568B (zh) 2004-12-10
CA2369126A1 (en) 2000-10-26
AU766199B2 (en) 2003-10-09
ATE270883T1 (de) 2004-07-15
PT1169026E (pt) 2004-10-29
DE60012163T2 (de) 2004-11-11
WO2000062769A3 (en) 2001-01-04
DE60012163D1 (de) 2004-08-19
AU4223100A (en) 2000-11-02
EP1169026B1 (en) 2004-07-14
HK1039568A1 (en) 2002-05-03
JP2002542189A (ja) 2002-12-10
WO2000062769A2 (en) 2000-10-26
BR0009862A (pt) 2002-01-08
EP1169026A2 (en) 2002-01-09

Similar Documents

Publication Publication Date Title
DK1039912T3 (da) Angiostatiske midler og præparater til behandling af GLC1A-glaukom
DE69521620T2 (de) Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom
PT839154E (pt) Peptidos e composicoes biologicamente activos sua utilizacao
ATE322258T1 (de) Methoden und zusammensetzungen zur modulation der aktivität der alpha-adrenergen rezeptoren
NO995544L (no) Forbindelser og metoder for inhibering av ekspresjonen av VCAM-1
ATE376835T1 (de) Verwendung von fucanen in der behandlung von adhäsion, arthritis und psoriasis
ATE433973T1 (de) Azolylaminoazine als inhibitoren von proteinkinasen
DE602004017736D1 (de) Verwendung von rapamycin und dessen derivaten zur behandlung von knochenverlust
BR9813767A (pt) Processo e composição para tratar glaucoma de glc1a
DK0889886T3 (da) Hidtil ukendte, i 6-stilling substituerede phenanthridiner
ATE288747T1 (de) Methoden und zusammensetzungen zur modulierung der aktivität von alpha-adrenergen rezeptoren
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
ATE345793T1 (de) Behandlung von xanthom mittels azetidinon- derivate als hemmer der sterol absorption
ATE275400T1 (de) Verwendung von melatonin zur behandlung der androgenetischen und diffusen alopezie vom weiblichen typ
ATE302002T1 (de) Verwendung von pyrazolderivaten zur behandlung von unfruchtbarkeit
DE69705421D1 (de) 15-fluoro-prostaglandine als augendrucksenkende mittel
DE60218153D1 (de) Verwendung von proteasom-inhibitoren zur behandlung des trockenen auges
CY1106409T1 (el) Παραγωγα κινολινης
DE60135972D1 (de) Orhthalmologische zusammenstellungen zur behandlung von ocularer hypertension
DK1169026T3 (da) Anvendelse af AP-1-aktivator til at behandle glaucom og okular hypertension
DK0950056T3 (da) N-(pyridinylamino)isoindoliner og beslægtede forbindelser
ATE305785T1 (de) Cd45 hemmer
DK1393277T3 (da) Anvendelse af NF-Kappa-B inhibitorer til behandling af öjentörhedslidelser
DK1017377T3 (da) Anvendelse af 6,7-substituerede 2-aminotetraliner til behandling af af cytokin fremkaldte inflammatoriske tilstande
ECSP003440A (es) Nuevos compuestos de pirimidinona y procedimiento